| Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Company Name | Sector | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nasdaq:halo | nasdaq:halo Shareholders | 13F-HR | 0001398344-22-010157 | Mar 31st, 2022 12:00AM | May 20th, 2022 12:00AM | May 20th, 2022 12:00AM | EP Wealth Advisors, LLC | 1540569 | HALOZYME THERAPEUTICS INC | COM | 40637H109 | 339 | 8500 | SH | SOLE | 8500 | 0 | 0 | May 21st, 2022 01:10AM | May 21st, 2022 01:10AM | Halozyme Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:halo | nasdaq:halo Shareholders | 13F-HR | 0001145443-22-000169 | Mar 31st, 2022 12:00AM | May 20th, 2022 12:00AM | May 20th, 2022 12:00AM | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 928047 | HALOZYME THERAPEUTICS INC | COM | 40637H109 | 9909 | 247811 | SH | DFND | 1,2,5,6 | 0 | 0 | 247811 | May 21st, 2022 01:09AM | May 21st, 2022 01:09AM | Halozyme Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:halo | nasdaq:halo Shareholders | 13F-HR/A | 0001062993-22-012945 | Dec 31st, 2021 12:00AM | May 19th, 2022 12:00AM | May 19th, 2022 12:00AM | CIM INVESTMENT MANAGEMENT INC | 1179791 | Halozyme Therapeutics, Inc. | COM | 40637H109 | 230 | 5712 | SH | SOLE | 5712 | 0 | 0 | May 20th, 2022 01:06AM | May 20th, 2022 01:06AM | Halozyme Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:halo | nasdaq:halo Shareholders | 13F-HR/A | 0001166588-22-000018 | Mar 31st, 2022 12:00AM | May 18th, 2022 12:00AM | May 18th, 2022 12:00AM | BNP PARIBAS ARBITRAGE, SA | 1166588 | Halozyme Therapeutics Inc | Equity | 40637H109 | 1810193 | 45391 | SH | DFND | 1 | 0 | 45391 | 0 | May 19th, 2022 01:12AM | May 19th, 2022 01:12AM | Halozyme Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:halo | nasdaq:halo Shareholders | 13F-HR | 0001606588-22-000006 | Mar 31st, 2022 12:00AM | May 17th, 2022 12:00AM | May 17th, 2022 12:00AM | One Capital Management, LLC | 1606588 | HALOZYME THERAPEUTICS INC | COM | 40637H109 | 486 | 12200 | SH | SOLE | 12200 | 0 | 0 | May 18th, 2022 01:14AM | May 18th, 2022 01:14AM | Halozyme Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:halo | nasdaq:halo Shareholders | 13F-HR | 0001595888-22-000014 | Mar 31st, 2022 12:00AM | May 17th, 2022 12:00AM | May 17th, 2022 12:00AM | JANE STREET GROUP, LLC | 1595888 | HALOZYME THERAPEUTICS INC | COM | 40637H109 | 730 | 18300 | SH | Put | DFND | 2 | 18300 | 0 | 0 | May 18th, 2022 01:13AM | May 18th, 2022 01:13AM | Halozyme Therapeutics | Health Care | Pharmaceuticals & Biotechnology |
| nasdaq:halo | nasdaq:halo Shareholders | 13F-HR | 0001595888-22-000014 | Mar 31st, 2022 12:00AM | May 17th, 2022 12:00AM | May 17th, 2022 12:00AM | JANE STREET GROUP, LLC | 1595888 | HALOZYME THERAPEUTICS INC | COM | 40637H109 | 1164 | 29200 | SH | Call | DFND | 2 | 0 | 0 | 0 | May 18th, 2022 01:13AM | May 18th, 2022 01:13AM | Halozyme Therapeutics | Health Care | Pharmaceuticals & Biotechnology |
| nasdaq:halo | nasdaq:halo Shareholders | 13F-HR | 0001595888-22-000014 | Mar 31st, 2022 12:00AM | May 17th, 2022 12:00AM | May 17th, 2022 12:00AM | JANE STREET GROUP, LLC | 1595888 | HALOZYME THERAPEUTICS INC | COM | 40637H109 | 1489 | 37345 | SH | DFND | 1 | 37345 | 0 | 0 | May 18th, 2022 01:13AM | May 18th, 2022 01:13AM | Halozyme Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:halo | nasdaq:halo Shareholders | 13F-HR | 0001420506-22-001112 | Mar 31st, 2022 12:00AM | May 17th, 2022 12:00AM | May 17th, 2022 12:00AM | Penn Capital Management Company, LLC | 1158202 | HALOZYME THERAPEUTICS INC | COM | 40637H109 | 8338 | 224849 | SH | SOLE | 224849 | 0 | 0 | May 18th, 2022 01:12AM | May 18th, 2022 01:12AM | Halozyme Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:halo | nasdaq:halo Shareholders | 13F-HR | 0001387131-22-006230 | Mar 31st, 2022 12:00AM | May 17th, 2022 12:00AM | May 17th, 2022 12:00AM | Advisors Asset Management, Inc. | 1297376 | HALOZYME THERAPEUTICS INC | COM | 40637H109 | 1094 | 27439 | SH | SOLE | 27439 | 0 | 0 | May 18th, 2022 01:12AM | May 18th, 2022 01:12AM | Halozyme Therapeutics | Health Care | Pharmaceuticals & Biotechnology |